/Investor DB

Mediphase Venture Partners

Venture capital

Late Stage · 2 people tracked

Find your way into Mediphase Venture Partners

Sign up to find every way you can get introduced to Mediphase Venture Partners

  • Your email: who you already know at Mediphase Venture Partners, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mediphase Venture Partners team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Fund manager profile

Mediphase Venture Partners is a venture fund manager. SEC filings show 1 venture fund on record, most recently MEDIPHASE VENTURE PARTNERS ANNEX FUND LP ($500K offering) filed February 2012.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

Stage
Late Stage
Tracked investments
1
Acquisitions
1

Team · 2 people

from public directories
Lawrence G. Miller· General Partner
Paul A. Howard· General Partner

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Tetraphase PharmaceuticalsinJan 2020acquired by La Jolla Pharmaceutical Company · Jul 2020 · $43M

Tetraphase Pharmaceuticals was a Watertown, MA biopharmaceutical company developing novel tetracycline antibiotics, including its lead drug Xerava (eravacycline) for multidrug-resistant bacterial infections.

BiotechWatertown, US

Guy Macdonald(Director)inLarry Edwards(Executive Officer, Director)inMaria Stahl(Executive Officer)inChristopher Watt(Executive Officer)

BoardL. Patrick Gage(Director)Keith Maher(Director)

Co-investorsBay City CapitalF-Prime CapitalExcel Venture ManagementFlagship Ventures

Exits · 1

1 acquisitions

Tetraphase Pharmaceuticalsacq. by La Jolla Pharmaceutical Company

Frequently asked questions

What stage does Mediphase Venture Partners invest at?
Mediphase Venture Partners invests at the Late Stage stage.

Similar investors

Featured in lists